Jun 13, 2023, 12:58 PM by

Jun 13, 2023, 12:58 PM by

Kalderos’ 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients

Jun 13, 2023, 12:58 PM by

Jun 13, 2023, 01:00 AM by User Not Found

Bio-IT World | BOSTON—The largest biotechnology conference in the world, the BIO International Conference, convened in Boston this week drawing over 20,000 attendees from more than 60 countries. In our post-pandemic world, the common thread throughout the conference was the need for global collaboration on our scientific challenges.

Jun 12, 2023, 10:57 AM by User Not Found

Bio-IT World | Illumina announced yesterday that Francis deSouza, Illumina's Chief Executive Officer and a Director, has resigned, effective Sunday, June 11.

Jun 8, 2023, 10:50 AM by

Government initiatives towards preventive healthcare, growing funding & investments in R&D activities, adoption of direct-to-consumer approach, increasing applications in personalized medicine and growing burden of chronic diseases are some of the major factors driving the growth of cellular health screening market.

Jun 8, 2023, 10:50 AM by

Jun 8, 2023, 10:50 AM by

Jun 8, 2023, 10:50 AM by

Jun 8, 2023, 10:50 AM by

Landenberg site strengthens supply to support lifesaving therapeutics for global customers

Jun 8, 2023, 10:50 AM by

AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology Integration of AARDEX MEMS AS and MEMS Mobile technology with Mevia's Medose dispenser offers opportunity to pilot next stage in reusable and real-time adherence solutions.

Jun 8, 2023, 10:50 AM by

Jun 8, 2023, 10:48 AM by

Qlucore, listed on Nasdaq First North, can now present the first results from an EU-funded project for improved diagnosis of lung cancer. The new classification model not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer.

Jun 8, 2023, 10:48 AM by

Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike

Jun 8, 2023, 10:48 AM by

Jun 8, 2023, 10:48 AM by

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer.

Jun 8, 2023, 10:48 AM by

Dr. Kevin Leiner to spearhead market authorizations for Micropep's groundbreaking natural micropeptide-based crop protection products.

Jun 8, 2023, 10:48 AM by

Almaden Genomics has named Ellen Gordon as Vice President, Head of Business Development. Gordon has worked for more than two decades on behalf of pharmaceutical and biotech companies to deliver insights and much-needed solutions, perfectly suiting her to help Almaden partner with clients and labs to accelerate genomic research and discovery through streamlined bioinformatics.

Jun 8, 2023, 10:48 AM by

Presenters will discuss the ICH M12 Drug Interaction Studies Guideline, and novel ADME models and methodologies.

Jun 8, 2023, 10:21 AM by

The global cancer biological therapy industry size was exhibited at USD 98.85 billion in 2022 and is projected to hit around USD 214 billion by 2032, growing at a CAGR of 8.03% during the forecast period 2023 to 2032.